Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (9)

2024

  1. Inflammation and weight change related to neurocognitive and functional impairment in diabetes and psychiatric disorders

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  2. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2019

  1. Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

    Oncotarget, Vol. 9, Núm. 4, pp. 4522-4536

2014

  1. Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype

    FASEB Journal, Vol. 28, Núm. 12, pp. 5163-5171

2012

  1. Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress

    Small, Vol. 8, Núm. 12, pp. 1895-1903

2010

  1. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

    Hepatology, Vol. 52, Núm. 1, pp. 115-125